Clearbridge Investments, LLC Novo Cure LTD Transaction History

Clearbridge Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $18,291 - $37,459	454 Added 0.57%	79,923 $3.32 Million
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $84,152 - $177,145	1,491 Added 1.91%	79,469 $4.78 Million
Q4 2022 Feb 10, 2023	SELL	$63.98 - $85.37 $14,523 - $19,378	-227 Reduced 0.29%	77,978 $5.72 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $7,206 - $9,494	-106 Reduced 0.14%	78,205 $5.94 Million
Q2 2022 Aug 11, 2022	BUY	$56.6 - $89.9 $263,020 - $417,765	4,647 Added 6.31%	78,311 $5.44 Million
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $4.43 Million - $6.23 Million	73,664 New	73,664 $6.1 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.